Shigeyuki Yamamoto Selected Research

Shigeyuki Yamamoto Research Topics

2	Infarction (Infarctions) 01/2017 - 10/2012
2	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2012 - 12/2004
2	Cognitive Dysfunction 09/2011 - 06/2011
1	Alzheimer Disease (Alzheimer's Disease) 03/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024
1	Stroke (Strokes) 01/2017
1	Neuroinflammatory Diseases 01/2017
1	Thrombosis (Thrombus) 10/2012
1	Mental Disorders (Mental Disorder) 01/2012
1	Overactive Urinary Bladder (Overactive Bladder) 09/2011
1	Schizophrenia (Dementia Praecox) 09/2010
1	Autistic Disorder (Autism) 04/2010
1	Hypoxia (Hypoxemia) 01/2008
1	Asphyxia (Suffocation) 01/2008
1	Fatigue 09/2003

2	N-methyl-3-piperidyl benzilateIBA 01/2012 - 06/2011
2	Cholinergic Agents (Cholinergics)IBA 01/2012 - 06/2011
2	Cholinergic ReceptorsIBA 01/2012 - 06/2011
1	Histone Deacetylase 6IBA 03/2024
1	LigandsIBA 03/2024
1	2- oxo- 7- methoxy- 8- butyloxy- 1,2- dihydroquinoline- 3- carboxylic acid cyclohexylamideIBA 01/2017
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2017
1	BMS 747158-02IBA 10/2012
1	Proteins (Proteins, Gene)FDA Link 10/2012
1	GABA-A Receptors (GABA(A) Receptor)IBA 10/2012
1	PK 11195 (PK11195)IBA 10/2012
1	triphenyltetrazoliumIBA 10/2012
1	AutoantibodiesIBA 01/2012
1	imidafenacinIBA 09/2011
1	oxybutynin (Tavor)FDA LinkGeneric 09/2011
1	Muscarinic AntagonistsIBA 09/2011
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 06/2011
1	Scopolamine (Hyoscine)FDA Link 06/2011
1	phosphohippolinIBA 09/2010
1	AdipokinesIBA 04/2010
1	AdiponectinIBA 04/2010
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2008
1	Serotonin (5 Hydroxytryptamine)IBA 12/2004
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2004
1	Hexobarbital (Hexenal)IBA 09/2003

1	Cesarean Section (Caesarean Section) 01/2008